T21	Exp 124 146	the interleukin-5 gene
T22	Exp 171 176	which
T23	Exp 265 280	the development
T24	Exp 336 340	that
T25	Exp 341 352	the outcome
T26	Exp 387 396	the ratio
T27	Exp 400 415	the two subsets
T28	Exp 455 474	the molecular basis
T29	Exp 544 546	We
T30	Exp 665 670	which
T31	Exp 590 614	the transcription factor
T32	Exp 713 724	Our studies
T33	Exp 751 755	that
T34	Exp 793 806	the IL-5 gene
T35	Exp 852 867	the GATA-3 site
T36	Exp 1049 1066	the IL-5 promoter
T37	Exp 1075 1094	the differentiation
T38	Exp 1339 1357	the GATA-3 protein
T39	Exp 1402 1413	the balance
T40	Exp 1522 1535	the treatment
R4	Coref Anaphora:T22 Antecedent:T4
R5	Coref Anaphora:T24 Antecedent:T41
R6	Coref Anaphora:T30 Antecedent:T42
T1	Protein 21 27	GATA-3
T2	Protein 128 141	interleukin-5
T3	Protein 149 162	Interleukin-5
T4	Protein 164 168	IL-5
T5	Protein 192 195	CD4
T6	Protein 419 422	CD4
T7	Protein 615 621	GATA-3
T8	Protein 625 629	IL-5
T9	Protein 756 762	GATA-3
T10	Protein 797 801	IL-5
T11	Protein 856 862	GATA-3
T12	Protein 907 911	IL-5
T13	Protein 968 974	GATA-3
T14	Protein 1014 1018	IL-5
T15	Protein 1053 1057	IL-5
T16	Protein 1104 1107	CD4
T17	Protein 1166 1172	GATA-3
T18	Protein 1343 1349	GATA-3
T19	Protein 1365 1371	GATA-3
T20	Protein 1477 1483	GATA-3
T41	Exp 316 335	increasing evidence
T42	Exp 653 663	EL-4 cells
